RE:Ceo
$57K was for "maintenance" ..."renovations" were for $130K ...on a house now on market for $1.25M...
I'll give the CEO a break for now even though I think there is a large cumulation of very major events, misteps and questionable decisions that should have him replaced, but kept within the ranks for what he has to bring to the equation given his long understanding of the market/players/CSS, etc.... Getting some separation between CVR Global and CVR Medical should also be a must. I believe he's too close and doesn't represent the interests of the shareholders as he does his own. I think he also came short on too many important matters - it's great if he works long hours, but ultimately it's about results. The delays of the FDA was a big deception for me, particularly with the fact that they even hired a specialty firm to assist them in that regard. The obvious insider trading (and confirmation with the committee on ethics just created) is also a big failure on his part in getting the right people and keeping control of the ship. He needs to be held more accountable. Having him replaced but kept within the troups could be a breath of fresh air for the company and could help create even more depth, perspective and strength to the company.
With this said, since we know they read what we write here, but no one within the company actually cares what we think here, speaking of fresh air, the Bid/Ask seems to indicate the stock is looking for a direction - at least on the OTC. Hoping that with all the negatives of the recent months/days and not uch positive to grasp on, hoping they've kept some positives to release when trading resumes - after all, they've certainly kept much information from the public for a long time. Hoping they had some wit and a game plan with that regards.
Investor presentation indicates "Executed" for the trials of Mayo Clinic and Wake Forest ...none of those ever had their results released publicly ...it would be nice to hear what they had to say. Perhaps this is the card they're keeping up their sleeve!? I would suspect they also already had some discussions for additional funding and maybe could issue a statement about this at the opportune moment. We'll also have to wait and see who the new directors will be on the BOD.
Also, what happened to the MOU's and LOI's with China and Korea? And all the other countries they indicated they had preliminary agreements or discussions with? Was there an expiration date to those?
I've written the company about this in the past, but never got any answer like everyone here... getting replies to inquiries would also be nice for a change.
Not bashing gratuitously and I remain a long and a believer in the CSS, but I feel we are owed more consideration, respect and integrity from the BOD and the CEO. I feel the recent changes are good, but more needs to be done/demonstrated...